Latest News for: takeda

Edit

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in ...

Black Hills Pioneer 23 Dec 2025
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 18, 2025-- ....
Edit

Takeda's Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in ...

Canada Newswire 22 Dec 2025
... document, any oral presentation, any question-and-answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited ("Takeda") regarding this release.
Edit

Takeda is BaseLaunch's new pharmaceutical partner (Switzerland Global Enterprise)

Public Technologies 18 Dec 2025
Takeda is BaseLaunch's new pharmaceutical partner ... In Switzerland, Takeda is based as Takeda Pharma AG in Opfikon in the Swiss canton of Zurich ... "We're thrilled to welcome Takeda to BaseLaunch," said Stephan Emmerth, Director of Base Launch.
Edit

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment (Form 6-K) (Takeda Pharmaceutical Co Ltd)

Public Technologies 18 Dec 2025
1 Takeda's Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment ... About Takeda ... For more information, visit www.takeda.com ... yuko.yoneyama@takeda.com.
Edit

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pharmiweb 18 Dec 2025
... document, any oral presentation, any question-and-answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release.
Edit

BaseLaunch Announces the Addition of Takeda as New Pharmaceutical Partner to its Biotech Venture Incubator

PR Newswire 16 Dec 2025
Takeda will join five existing leading pharma company partners supporting and funding promising drug development startups ... "We're thrilled to welcome Takeda to BaseLaunch ... In addition to Takeda, these ...
Edit

Amendment to Beneficial Ownership Report (Form SC 13G/A) (Takeda Pharmaceutical Co Ltd)

Public Technologies 10 Dec 2025
). The text version of this document is not available ... Takeda Pharmaceutical Co.
Edit

Notice of Proposed Sale of Securities (Form 144) (Takeda Pharmaceutical Co Ltd)

Public Technologies 09 Dec 2025
). The text version of this document is not available ... Takeda Pharmaceutical Co.
Edit

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera (Form 6-K) (Takeda Pharmaceutical Co Ltd)

Public Technologies 08 Dec 2025
1 Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera ... Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide ... About Takeda.
Edit

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and ...

Hastings Tribune 06 Dec 2025
NEWARK, Calif. & OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 6, 2025-- ... .
Edit

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera

Pharmiweb 06 Dec 2025
... document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release.
Edit

Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda for Next-Generation IO and ADC Therapies

Corvallis Gazette-Times 05 Dec 2025
... the global strategic collaboration with Takeda (TSE.
Edit

Takeda Announces Closing of Strategic Partnership with Innovent Biologics for Next-Generation Investigational Oncology Medicines (Takeda Pharmaceutical Co Ltd)

Public Technologies 04 Dec 2025
Takeda will lead global co-development and U.S ... About Takeda ... ## About Takeda Takeda is focused on creating better health for people and a brighter future for the world ... For more information, visit [www.takeda.com](https.//www.takeda.com/).
Edit

Better health for all: Takeda’s continuous efforts for health equity across Asia Pacific

Vietnam News 02 Dec 2025
Takeda’s vision is to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet ... How does Takeda address healthcare gaps? ... This marks a pivotal moment in Takeda’s growth trajectory.
Edit

Colorectal Cancer Market Set to Grow Substantially Through 2034, DelveInsight Projects | Takeda, Genentech/Seagen, AstraZeneca ...

GetNews 02 Dec 2025
The Colorectal Cancer market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period ... Some of the key facts of the Colorectal Cancer Market Report. ... In November 2025, The U.S ... (Nasdaq ... 188RNL-BAM ... PCS11T ... 1.

Article Search

tools
×
×
×
×